Test Overview
Test Methodology

LC-MS/MS

Test Usage

Paliperidone (9-hydroxyrisperidone) is the active ingredient in Invega extended-release tablets. Paliperidone is also the major active metabolite of Risperidone. Steady-state concentrations are typically attained within 4 to 5 days of dosing. Following daily administration of 12 mg extended release formulation, paliperidone steady state plasma concentrations ranged from 30 to 40 ng/mL.

Reference Range *

Reporting limit determined each analysis

* Reference ranges may change over time. Please refer to the original patient report when evaluating results.

Test Details
Days Set Up
Monday - Sunday
Analytic Time

8 - 12 days

Soft Order Code
FPALI
MiChart Code
FPALI
Laboratory
Sendout
Reference Laboratory
Mayo FPALI (NMS Labs)
Section
Special Testing
Specimen Requirements
Collection

Red top only, no SST

Collection Instructions

Collect specimen in a red top tube (NO SST). Spin and aliquot into a plastic, screw capped tube. Send to Specimen Processing refrigerated

Rejection Criteria
Specimen collected in anything but a red top tube
Yellow Top Tube
Normal Volume
1 mL serum
Minimum Volume
0.5 mL serum
Storage Temperature
Ambient is also acceptable
Additional Information

Test sent to Mayo Clinic Labs; performed by NMS labs

Billing
CPT Code
80342
Fee Code
AA588
Resources